Structural characterization of the α-N-acetylglucosaminidase, a key enzyme in the pathogenesis of Sanfilippo syndrome B

被引:14
作者
Birrane, Gabriel [1 ]
Dassier, Anne-Laure [1 ]
Romashko, Alla [2 ]
Lundberg, Dianna [2 ]
Holmes, Kevin [2 ]
Cottle, Thomas [1 ]
Norton, Angela W. [2 ]
Zhang, Bohong [2 ]
Concino, Michael F. [2 ]
Meiyappan, Muthuraman [2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Med, Div Expt Med, 99 Brookline Ave, Boston, MA 02215 USA
[2] Takeda Pharmaceut Co Ltd, Res US, Discovery Therapeut, 125 Binney St, Cambridge, MA 02142 USA
基金
美国国家卫生研究院;
关键词
Mucopolysaccharidosis III B; Sanfilippo syndrome B; Heparan sulfate; Crystal structure; MUCOPOLYSACCHARIDOSIS TYPE IIIB; MOLECULAR DEFECTS; GENE; IDENTIFICATION; MUTATIONS; COMPLEX;
D O I
10.1016/j.jsb.2019.02.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucopolysaccharidosis III B (MPS III-B) is a rare lysosomal storage disorder caused by deficiencies in Alpha-N-acetylglucosaminidase (NAGLU) for which there is currently no cure, and present treatment is largely supportive. Understanding the structure of NAGLU may allow for identification of novel therapeutic targets for MPS IIIB. Here we describe the first crystal structure of human NAGLU, determined to a resolution of 2.3 angstrom. The crystal structure reveals a novel homotrimeric configuration, maintained primarily by hydrophobic and electrostatic interactions via domain II of three contiguous domains from the N- to C-terminus. The active site cleft is located between domains II and III. Catalytic glutamate residues, E316 and E446, are located at the top of the (alpha/beta)(8) barrel structure in domain II. We utilized the three-dimensional structure of NAGLU to map several MPS III-B mutations, and hypothesize their functional consequences. Revealing atomic level structural information about this critical lysosomal enzyme paves the way for the design of novel therapeutics to target the underlying causes of MPS III-B.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 28 条
  • [1] Aronovich EL, 1996, AM J HUM GENET, V58, P75
  • [2] Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB)
    Beesley, CE
    Jackson, M
    Young, EP
    Vellodi, A
    Winchester, BG
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (05) : 759 - 767
  • [3] Identification of 12 novel mutations in the α-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB)
    Beesley, GE
    Young, EP
    Vellodi, A
    Winchester, BG
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (11) : 910 - 914
  • [4] Bunge S, 1999, J MED GENET, V36, P28
  • [5] ELBEIN AD, 1990, J BIOL CHEM, V265, P15599
  • [6] Emre Serap, 2002, Hum Mutat, V19, P184, DOI 10.1002/humu.9009
  • [7] Features and development of Coot
    Emsley, P.
    Lohkamp, B.
    Scott, W. G.
    Cowtan, K.
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2010, 66 : 486 - 501
  • [8] POVScript+:: a program for model and data visualization using persistence of vision ray-tracing
    Fenn, TD
    Ringe, D
    Petsko, GA
    [J]. JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2003, 36 (02) : 944 - 947
  • [9] Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB
    Ficko-Blean, Elizabeth
    Stubbs, Keith A.
    Nemirovsky, Oksana
    Vocadlo, David J.
    Boraston, Alisdair B.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (18) : 6560 - 6565
  • [10] Structural analysis of a bacterial exo-α-d-N-acetylglucosaminidase in complex with an unusual disaccharide found in class III mucin
    Ficko-Blean, Elizabeth
    Boraston, Alisdair B.
    [J]. GLYCOBIOLOGY, 2012, 22 (05) : 590 - 595